Emre Isin

Emre Isin is the Global Head of Drug Metabolism and Pharmacokinetics at Servier, serving as Senior Director since 2020. They completed a Ph.D. in Chemistry at Virginia Tech, where their research focused on neuroprotective agents and monoamine oxidase substrate properties. Emre's career includes notable roles such as Director at UCB, leading biotransformation teams, and postdoctoral fellow at Vanderbilt University Medical Center, specializing in cytochrome P450 studies. Additionally, they have held positions at AstraZeneca R&D, overseeing teams dedicated to optimizing drug candidate parameters.